CL2022000054A1 - Polimorfos de (r)-n-(5-(5-etil-1,2,4-oxadiazol-3-il)-2,3-dihidro-1h-inden-1-il)-1-metil-1h-pirazol-4-car- boxamida. - Google Patents
Polimorfos de (r)-n-(5-(5-etil-1,2,4-oxadiazol-3-il)-2,3-dihidro-1h-inden-1-il)-1-metil-1h-pirazol-4-car- boxamida.Info
- Publication number
- CL2022000054A1 CL2022000054A1 CL2022000054A CL2022000054A CL2022000054A1 CL 2022000054 A1 CL2022000054 A1 CL 2022000054A1 CL 2022000054 A CL2022000054 A CL 2022000054A CL 2022000054 A CL2022000054 A CL 2022000054A CL 2022000054 A1 CL2022000054 A1 CL 2022000054A1
- Authority
- CL
- Chile
- Prior art keywords
- inden
- oxadiazol
- polymorphs
- carboxamide
- pyrazole
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4245—Oxadiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Cardiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Heart & Thoracic Surgery (AREA)
- General Chemical & Material Sciences (AREA)
- Hospice & Palliative Care (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962875350P | 2019-07-17 | 2019-07-17 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CL2022000054A1 true CL2022000054A1 (es) | 2022-10-07 |
Family
ID=71995103
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CL2022000054A CL2022000054A1 (es) | 2019-07-17 | 2022-01-10 | Polimorfos de (r)-n-(5-(5-etil-1,2,4-oxadiazol-3-il)-2,3-dihidro-1h-inden-1-il)-1-metil-1h-pirazol-4-car- boxamida. |
Country Status (25)
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SG11202006296YA (en) | 2018-01-19 | 2020-08-28 | Cytokinetics Inc | Dihydrobenzofuran and inden analogs as cardiac sarcomere inhibitors |
| JP7438148B2 (ja) | 2018-06-26 | 2024-02-26 | サイトキネティックス, インコーポレイテッド | 心臓サルコメア阻害剤 |
| EP3814343B1 (en) | 2018-06-26 | 2023-01-11 | Cytokinetics, Inc. | Cardiac sarcomere inhibitors |
| MA53491A (fr) | 2018-08-31 | 2021-09-15 | Cytokinetics Inc | Inhibiteurs de sarcomes cardiaques |
| MX2022000498A (es) | 2019-07-17 | 2022-02-03 | Cytokinetics Inc | Polimorfos de (r)-n-(5-(5-isopropil-1,2,4-oxadiazol-3-il)-2,3-dihi dro-1h-inden-1-il) -2-metil-2h- tetrazol-5-carboxamida. |
| KR20240015622A (ko) | 2021-03-04 | 2024-02-05 | 싸이토키네틱스, 인코포레이티드 | 심장 근절 억제제 |
| EP4370116B1 (en) | 2021-07-16 | 2025-01-15 | Cytokinetics, Inc. | Aficamten dosage regimens for treating obstructive hypertrophic cardiomyopathy |
| JP2024530111A (ja) | 2021-08-03 | 2024-08-16 | サイトキネティックス, インコーポレイテッド | アフィカムテンを調製するための工程 |
| US20240091203A1 (en) | 2022-07-20 | 2024-03-21 | Cytokinetics, Incorporated | Methods for treating non-obstructive hypertrophic cardiomyopathy |
| JP2025525913A (ja) | 2022-08-04 | 2025-08-07 | サイトキネティックス, インコーポレイテッド | 閉塞性肥大型心筋症を治療するための方法 |
| WO2024134498A1 (en) | 2022-12-22 | 2024-06-27 | Assia Chemical Industries Ltd. | Solid state forms of aficamten and process for preparation thereof |
| CN120712262A (zh) * | 2023-03-02 | 2025-09-26 | 苏州科睿思制药有限公司 | Aficamten的共晶及其制备方法和用途 |
| WO2025198687A1 (en) | 2024-03-20 | 2025-09-25 | Cytokinetics, Incorporated | Methods for treating heart diseases |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SG11202006296YA (en) * | 2018-01-19 | 2020-08-28 | Cytokinetics Inc | Dihydrobenzofuran and inden analogs as cardiac sarcomere inhibitors |
| JP2024530111A (ja) * | 2021-08-03 | 2024-08-16 | サイトキネティックス, インコーポレイテッド | アフィカムテンを調製するための工程 |
-
2020
- 2020-07-16 LT LTEPPCT/US2020/042387T patent/LT3999180T/lt unknown
- 2020-07-16 FI FIEP20753562.6T patent/FI3999180T3/fi active
- 2020-07-16 PT PT207535626T patent/PT3999180T/pt unknown
- 2020-07-16 DK DK20753562.6T patent/DK3999180T3/da active
- 2020-07-16 AU AU2020313965A patent/AU2020313965B2/en active Active
- 2020-07-16 HR HRP20240713TT patent/HRP20240713T1/hr unknown
- 2020-07-16 HU HUE20753562A patent/HUE066891T2/hu unknown
- 2020-07-16 WO PCT/US2020/042387 patent/WO2021011807A1/en not_active Ceased
- 2020-07-16 RS RS20240598A patent/RS65611B1/sr unknown
- 2020-07-16 SI SI202030443T patent/SI3999180T1/sl unknown
- 2020-07-16 MX MX2022000504A patent/MX2022000504A/es unknown
- 2020-07-16 BR BR112022000494A patent/BR112022000494A2/pt unknown
- 2020-07-16 IL IL289875A patent/IL289875B1/en unknown
- 2020-07-16 CA CA3144975A patent/CA3144975A1/en active Pending
- 2020-07-16 SM SM20240224T patent/SMT202400224T1/it unknown
- 2020-07-16 ES ES20753562T patent/ES2980885T3/es active Active
- 2020-07-16 PL PL20753562.6T patent/PL3999180T3/pl unknown
- 2020-07-16 KR KR1020227004639A patent/KR20220084008A/ko active Pending
- 2020-07-16 EP EP24174636.1A patent/EP4487911A1/en active Pending
- 2020-07-16 CN CN202411172308.4A patent/CN118908951A/zh active Pending
- 2020-07-16 US US17/627,599 patent/US20220315571A1/en active Pending
- 2020-07-16 JP JP2022502215A patent/JP7624431B2/ja active Active
- 2020-07-16 CN CN202411172321.XA patent/CN119119018A/zh active Pending
- 2020-07-16 PH PH1/2022/550123A patent/PH12022550123A1/en unknown
- 2020-07-16 TW TW109124093A patent/TWI865562B/zh active
- 2020-07-16 EP EP20753562.6A patent/EP3999180B1/en active Active
- 2020-07-16 CN CN202080059660.0A patent/CN114555590B/zh active Active
-
2022
- 2022-01-10 CL CL2022000054A patent/CL2022000054A1/es unknown
-
2025
- 2025-01-20 JP JP2025007662A patent/JP7755090B2/ja active Active
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2022000504A (es) | Polimorfos de (r)-n-(5-(5-etil-1,2,4-oxadiazol-3-il)-2,3-dihidro-1 h-inden-1-il)-1-metil-1h-pirazol-4-carboxamida. | |
| CL2022000089A1 (es) | Polimorfos de (r)-n-(5-(5-isopropil-1,2,4-oxadiazol-3-il)-2,3-dihidro-1h-inden-1-il) -2-metil-2h- tetrazole-5-carboxamida. | |
| MX2022000708A (es) | Formulaciones orales de inhibidores de sarcomeros cardiacos. | |
| EA202091893A1 (ru) | Новые кристаллические формы | |
| CO2021007056A2 (es) | Nuevos compuestos heterocíclicos | |
| EA202091506A1 (ru) | Триазол n-связанные карбамоил циклогексильные кислоты в качестве антагонистов lpa | |
| MX388725B (es) | Nuevos derivados de isoxazolil eter como moduladores alostericos positivos (pam) de acido gamma-aminobutirico (gaba) a alfa5. | |
| BR112018001017A2 (pt) | inibidores do receptor de fator-1 de estimulação de colônia (csf-1r) | |
| EA201691302A1 (ru) | Новые гетероциклические соединения | |
| UY37647A (es) | Amidas de ácido n–(1,3,4–oxadiazol–2–il)arilcarboxílico sustituidas y su compuesto como herbicidas | |
| DK3908584T3 (da) | Krystalformer af 1-(1,2-dimethylpropyl)-n-ethyl-5-methyl-n-pyridazin-4-ylpyrazol-4-carboxamid | |
| UY38017A (es) | Polimorfos de 4-[5-(3,5-dicloro-4-fluorofenil)-4,5-dihidro-5-(trifluorometil)-3-isoxazolil]-n-(2-etil-3-oxo-4-isoxazolidinil)-2-metilbenzamida | |
| IL260403B (en) | Formulations of 2-(4-chlorophenyl)-n-((2-(2,6-dioxopiperidin-3-yl)-1-oxoisoindolin-5-yl)methyl)-2,2-difluoroacetamide | |
| DK3658547T3 (da) | Fremgangsmåde til fremstilling af n-(5-(4-(4-formyl-3-phenyl-1h-pyrazol-1-yl)pyrimidin-2-ylamino)-4-methoxy-2-morpholinophenyl)acrylamid | |
| MX2020013518A (es) | Nuevos derivados de isoxazolil eter como moduladores alostericos positivos (pam) del receptor de acido gamma-aminobutirico a alfa5 (gaba a alfa5). | |
| EA202091692A1 (ru) | Амидинзамещенные бензоильные производные, пригодные в качестве гербицидов | |
| PY2027945A (es) | Tienilhidroxiisoxazolinas y derivados de las mismas | |
| AR091565A1 (es) | N-[4-(quinolin-4-iloxi)ciclohexil(metil)](hetero)aril-carboxamidas como antagonistas del receptor de androgenos, su produccion y usos como productos medicinales | |
| MX386696B (es) | Proceso para producir analogos de anillo de arilomicina | |
| MX381722B (es) | Compuestos. | |
| CO2021003295A2 (es) | (r)-5-carbamoilpiridin-3-il-2-metil-4-(3-(trifluorometoxi)bencil)piperazin-1-carboxilato cristalino, composiciones y sus métodos de uso | |
| EP3773536A4 (en) | 1,4-SUBSTITUTED ISOCHINOLINE INHIBITORS OF KEAP1 / NRF2-PROTEIN-PROTEIN INTERACTION | |
| HK40075684B (en) | Polymorphs of (r)-n-(5-(5-ethyl-1,2,4-oxadiazol-3-yl)-2,3-dihydro-1h-inden-1-yl)-1-methyl-1h-pyrazole-4-carboxamide | |
| MX391061B (es) | Combinacion herbicida ternaria | |
| PY2027937A (es) | Hidroxiisoxazolinas y derivados de las mismas |